CoChat

Decanoic acid extends lifespan and modulates metabolism in models of PLA2G6 -associated neurodegeneration

Open access

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index; none of the 52 sources its claims cite is checked for support yet.

Abstract

PLA2G6-associated neurodegeneration (PLAN) is a group of rare genetic disorders characterised by progressive neurodegeneration resulting from mutations in the PLA2G6 gene, encoding a calcium-independent phospholipase enzyme. Here, we have explored the effects of decanoic acid (DA), a medium-chain fatty acid, in the fruit fly Drosophila melanogaster models of PLAN and show that DA treatment significantly extends the lifespan, reduces bang sensitivity and improves resistance to heat shock stress. Transcriptional analysis showed that DA affects genes in key signalling pathways, including Insulin/Insulin-like Growth Factor, mTOR, heat shock response, Sirtuin, autophagy and mitochondrial function. Additionally, DA treatment alters the metabolite profiles in PLAN model flies, with the most pronounced changes observed in gut tissue. Pathway analysis of these metabolomic shifts highlights potential therapeutic effects of DA in several pathways, including ATP-binding cassette (ABC) transporters, purine metabolism, cAMP signalling and neuroactive ligand-receptor interactions. These findings suggest that DA may be a promising therapeutic agent for PLAN, offering insights into the mechanisms of the disease and paving the way for future research on medium-chain fatty acids as potential treatments for neurodegenerative diseases.

Overview

CoChat Summary

TL;DR

In two Drosophila models of PLA2G6-associated neurodegeneration, decanoic acid treatment extended lifespan, reduced bang sensitivity, and improved heat-shock stress resistance in young flies. Transcriptional and metabolomic profiling implicated IIS/TOR, sirtuin, heat-shock, autophagy, ABC transporter, purine, cAMP, and neuroactive ligand–receptor pathways.

Key findings

  • DA extended median lifespan in both PLAN models: iPLA-VIAΔ174 at 1 mM DA; iPLA2-VIAEY05103 at 250 μM and 1 mM. 1 mM DA extended lifespan by 13% in iPLA-VIAΔ174 versus ∼8% in iPLA2-VIAEY05103 (n=150 per group).
  • DA (250 μM) reduced age-dependent bang sensitivity in iPLA-VIAΔ174 flies: day 15 DMSO, 50 μM and 1 mM groups had longer recovery than day 8 (P<0.0001), while 250 μM did not (P=0.0609), and 250 μM slowed the slope of recovery-time increase (P<0.0001; n=50–75). 50 μM DA improved heat-shock resistance in young (3-day-old) iPLA-VIAΔ174 flies (n=150), but DA did not affect starvation or oxidative stress resistance or SOD/catalase activity.
  • In iPLA-VIAΔ174 flies, DA altered expression of InR (increased at days 5 and 27; treatment/age interaction P=0.0035), 4E-BP (elevated at days 5 and 27 but reduced at day 20; P<0.0001), dSir2 (increased at day 27; interaction P=0.1069), Hsp70 (elevated at all time points; P<0.0001), and Atg1 (increased at day 27; P=0.0009); foxo and mitochondrial genes were unchanged.
  • Metabolomics found DA effects across brain, gut, muscle and whole flies, most pronounced in brain and gut, with gut showing the highest number of shared DA-modulated metabolites; enriched pathways included ABC transporters, purine metabolism, cAMP signalling and neuroactive ligand–receptor interactions.

Methods

  • Drosophila melanogaster: two PLAN models lacking iPLA2-VIA expression (iPLA-VIAΔ174 and iPLA2-VIAEY05103) plus WT wDah+; female flies; DA in DMSO added to food at 50 μM, 250 μM or 1 mM, with DMSO control; lifespan assays used 150 female flies per genotype/treatment.
  • Phenotypic and molecular assays: lifespan, climbing, locomotion, bang sensitivity, heat-shock, starvation, oxidative stress, antioxidant enzyme activity, qPCR, western blot, and metabolomics of brain, gut, muscle and whole flies using HILIC and reverse-phase LC-MS; 42 identified metabolites from 23 pathways and 218 structurally distinct metabolites were analysed.
  • Statistics: log-rank tests for survival; two-way ANOVA with Tukey’s multiple comparisons and linear regression for other assays; PLS-DA with CV-ANOVA for metabolomics; pathway enrichment and conditional probability analyses.

Limitations

  • Stated: the study focused on female flies because male aggression and higher baseline activity could add variability; DA did not improve climbing/locomotion healthspan, older-fly heat resistance, starvation or oxidative stress resistance, or SOD/catalase activity; the exact molecular mechanisms remain to be fully elucidated, and gene expression alone may not capture IIS functional output.
  • Evident from the text: findings are limited to Drosophila PLAN models, not human patients; qPCR and metabolomics used n=3 biological replicates; IIS/TOR/FOXO/4E-BP effects were inferred from transcript levels rather than direct activity or phosphorylation measurements, and mitochondrial function was not directly assayed here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1242/dmm.052184

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. DA extends the lifespan in both Drosophila PLAN models. (A) qPCR analysis of iPLA-VIA expression levels in wild-type (WT) and iPLA-VIAΔ174 flies (n=3). (B) Validation of iPLA-VIA expression levels in WT and iPLA-VIAEY05103 flies (n=3). (C) Lifespan of iPLA-VIAΔ174 flies is significantly longer when the flies are fed food containing 1 mM DA (n=150). (D) The lifespan of iPLA-VIAEY05103 flies is significantly extended when they are fed 250 μM and 1 mM DA (n=150). Statistical significance in A and B was determined using an unpaired, two-tailed t-test (****P<0.0001). RQ represent relative expression level. Data in C and D were analysed using the log-rank test, with P-values comparing the given DA concentration to control. Lifespan is presented as survival curves, showing the percentage of surviving flies over time. Each experiment was repeated at least twice with similar results (Fig. S2).
Fig. 1. DA extends the lifespan in both Drosophila PLAN models. (A) qPCR analysis of iPLA-VIA expression levels in wild-type (WT) and iPLA-VIAΔ174 flies (n=3). (B) Validation of iPLA-VIA expression levels in WT and iPLA-VIAEY05103 flies (n=3). (C) Lifespan of iPLA-VIAΔ174 flies is significantly longer when the flies are fed food containing 1 mM DA (n=150). (D) The lifespan of iPLA-VIAEY05103 flies is significantly extended when they are fed 250 μM and 1 mM DA (n=150). Statistical significance in A and B was determined using an unpaired, two-tailed t-test (****P<0.0001). RQ represent relative expression level. Data in C and D were analysed using the log-rank test, with P-values comparing the given DA concentration to control. Lifespan is presented as survival curves, showing the percentage of surviving flies over time. Each experiment was repeated at least twice with similar results (Fig. S2).CC BY · PubMed Central
Fig. 2. DA reduces bang sensitivity and improves heat-shock stress resistance of iPLA-VIAΔ174 flies. (A) Bang-sensitivity assay in iPLA-VIAΔ174 flies at days 8 and 15 post-eclosion, fed with 50 μM, 250 μM and 1 mM DA. Flies treated with DMSO (control), 50 μM and 1 mM DA showed a significant increase in recovery time from mechanical stress-induced paralysis between day 8 and day 15 (P<0.0001), whereas flies fed 250 μM DA did not show a significant change (P=0.0609) (n=50-75). (B) Treatment with 250 μM DA significantly slowed the rate of increase (slope) of recovery time in iPLA-VIAΔ174 flies compared to control flies (P<0.0001) (n=50-75). (C) Heat-shock stress resistance assay in young (3-day-old) iPLA-VIAΔ174 flies fed DA at different concentrations (50 μM, 250 μM and 1 mM). Flies fed 50 μM DA (blue line) exhibited significantly improved heat-shock stress resistance compared to the controls (red line) (n=150). In A, statistical analysis was performed using two-way ANOVA with Tukey's multiple comparisons test in GraphPad Prism. In B, a simple linear regression analysis was used in GraphPad Prism. In C, data were analysed using the log-rank test. Differences were considered significant at P<0.05. Error bars represent s.e.m. ****P<0.0001; n.s., not significant. The bang-sensitivity assay was repeated at least twice with similar results.
Fig. 2. DA reduces bang sensitivity and improves heat-shock stress resistance of iPLA-VIAΔ174 flies. (A) Bang-sensitivity assay in iPLA-VIAΔ174 flies at days 8 and 15 post-eclosion, fed with 50 μM, 250 μM and 1 mM DA. Flies treated with DMSO (control), 50 μM and 1 mM DA showed a significant increase in recovery time from mechanical stress-induced paralysis between day 8 and day 15 (P<0.0001), whereas flies fed 250 μM DA did not show a significant change (P=0.0609) (n=50-75). (B) Treatment with 250 μM DA significantly slowed the rate of increase (slope) of recovery time in iPLA-VIAΔ174 flies compared to control flies (P<0.0001) (n=50-75). (C) Heat-shock stress resistance assay in young (3-day-old) iPLA-VIAΔ174 flies fed DA at different concentrations (50 μM, 250 μM and 1 mM). Flies fed 50 μM DA (blue line) exhibited significantly improved heat-shock stress resistance compared to the controls (red line) (n=150). In A, statistical analysis was performed using two-way ANOVA with Tukey's multiple comparisons test in GraphPad Prism. In B, a simple linear regression analysis was used in GraphPad Prism. In C, data were analysed using the log-rank test. Differences were considered significant at P<0.05. Error bars represent s.e.m. ****P<0.0001; n.s., not significant. The bang-sensitivity assay was repeated at least twice with similar results.CC BY · PubMed Central
Fig. 3. DA modulates the expression of key genes involved in insulin signalling, sirtuin regulation, heat-shock response and autophagy initiation. (A-E) In iPLA-VIAΔ174 flies fed 1 mM DA or control food (DMSO): (A) InR expression is increased at days 5 and 27 compared to age-matched controls (treatment/age interaction: P=0.0035); (B) 4E-BP expression is elevated at days 5 and 27 but reduced at day 20 (****P<0.0001); (C) Drosophila Sirt1 (dSir2) expression is increased at day 27, although the treatment/age interaction is not significant (P=0.1069); (D) Hsp70 expression is elevated across all time points (****P<0.0001); (E) Atg1 expression is increased at day 27 (P=0.0009). Statistical analyses of all RQ values were performed using two-way ANOVA with Tukey's multiple comparisons test in GraphPad Prism. Error bars represent s.e.m. Significance is indicated as *P<0.0332, **P<0.0021, ***P<0.0002, ****P<0.0001; n.s., not significant (n=3).
Fig. 3. DA modulates the expression of key genes involved in insulin signalling, sirtuin regulation, heat-shock response and autophagy initiation. (A-E) In iPLA-VIAΔ174 flies fed 1 mM DA or control food (DMSO): (A) InR expression is increased at days 5 and 27 compared to age-matched controls (treatment/age interaction: P=0.0035); (B) 4E-BP expression is elevated at days 5 and 27 but reduced at day 20 (****P<0.0001); (C) Drosophila Sirt1 (dSir2) expression is increased at day 27, although the treatment/age interaction is not significant (P=0.1069); (D) Hsp70 expression is elevated across all time points (****P<0.0001); (E) Atg1 expression is increased at day 27 (P=0.0009). Statistical analyses of all RQ values were performed using two-way ANOVA with Tukey's multiple comparisons test in GraphPad Prism. Error bars represent s.e.m. Significance is indicated as *P<0.0332, **P<0.0021, ***P<0.0002, ****P<0.0001; n.s., not significant (n=3).CC BY · PubMed Central
Fig. 4. PLS-DA scores plots showing the effect of ageing and DA treatment of metabolite profile in brain and gut. Ellipses identify respective treatment groups, with blue indicating DMSO-treated and yellow indicating DA-treated samples. (A) PLS-DA score plots coloured by treatment and age in the brain of iPLA-VIAEY05103 flies (R2X=0.627 R2Y=0.809 Q2=0.505 CV-ANOVA=6.42×10−7). (B) PLS-DA score plots coloured by treatment and age in the brain of iPLA-VIAΔ174 flies (R2X=0.543 R2Y=0.517 Q2=0.752 CV-ANOVA=5.43×10−5). (C) PLS-DA score plots coloured by treatment and age in the gut of iPLA-VIAEY05103 flies (R2X=0.553 R2Y=0.919 Q2=0.882 CV-ANOVA=6.61×10−8). (D) PLS-DA scores plots coloured by treatment and age in the gut of iPLA-VIAΔ174 flies (R2X=0.274 R2Y=0.862 Q2=0.787 CV-ANOVA=0.0001) (n=3).
Fig. 4. PLS-DA scores plots showing the effect of ageing and DA treatment of metabolite profile in brain and gut. Ellipses identify respective treatment groups, with blue indicating DMSO-treated and yellow indicating DA-treated samples. (A) PLS-DA score plots coloured by treatment and age in the brain of iPLA-VIAEY05103 flies (R2X=0.627 R2Y=0.809 Q2=0.505 CV-ANOVA=6.42×10−7). (B) PLS-DA score plots coloured by treatment and age in the brain of iPLA-VIAΔ174 flies (R2X=0.543 R2Y=0.517 Q2=0.752 CV-ANOVA=5.43×10−5). (C) PLS-DA score plots coloured by treatment and age in the gut of iPLA-VIAEY05103 flies (R2X=0.553 R2Y=0.919 Q2=0.882 CV-ANOVA=6.61×10−8). (D) PLS-DA scores plots coloured by treatment and age in the gut of iPLA-VIAΔ174 flies (R2X=0.274 R2Y=0.862 Q2=0.787 CV-ANOVA=0.0001) (n=3).CC BY · PubMed Central
Fig. 5. Heat map of metabolites altered by DA in Drosophila PLAN models. The heat map provides an overview of changes in the relative abundance of individual metabolites detected across various tissues, including the brain, gut, muscle and whole flies, from two Drosophila PLAN models treated with either DMSO (control) or 250 μM DA. Metabolites are indicated based on their pattern of alteration: those highlighted in red represent metabolites that showed a significant (P<0.05) interaction between DA treatment and age across both PLAN models; those in orange indicate metabolites affected exclusively in the iPLA-VIAEY05103; and those in yellow indicate metabolites affected exclusively in the iPLA-VIAΔ174. The results showed a pronounced effect of DA in the gut tissue, where the highest number of shared metabolic alterations across both PLAN models was observed. Statistical analysis was conducted using a two-way ANOVA with Tukey's multiple comparisons tests in GraphPad Prism for each metabolite in each tissue sample. The treatment/age interaction is highly significant (P<0.0001) (n=3).
Fig. 5. Heat map of metabolites altered by DA in Drosophila PLAN models. The heat map provides an overview of changes in the relative abundance of individual metabolites detected across various tissues, including the brain, gut, muscle and whole flies, from two Drosophila PLAN models treated with either DMSO (control) or 250 μM DA. Metabolites are indicated based on their pattern of alteration: those highlighted in red represent metabolites that showed a significant (P<0.05) interaction between DA treatment and age across both PLAN models; those in orange indicate metabolites affected exclusively in the iPLA-VIAEY05103; and those in yellow indicate metabolites affected exclusively in the iPLA-VIAΔ174. The results showed a pronounced effect of DA in the gut tissue, where the highest number of shared metabolic alterations across both PLAN models was observed. Statistical analysis was conducted using a two-way ANOVA with Tukey's multiple comparisons tests in GraphPad Prism for each metabolite in each tissue sample. The treatment/age interaction is highly significant (P<0.0001) (n=3).CC BY · PubMed Central
Fig. 6. The ABC transporter, cAMP signalling, purine metabolism and neuroactive ligand-receptor interaction are altered by DA in both PLAN models. (A-D) Enrichment is the total number of significant metabolites per pathway, correcting for pathway size. DA treatment and ageing in brain, gut, muscle and whole flies. Metabolic pathways that are altered by DA in the brain (A), gut (B), muscle (C) and the whole fly (D) are found in both PLAN models.
Fig. 6. The ABC transporter, cAMP signalling, purine metabolism and neuroactive ligand-receptor interaction are altered by DA in both PLAN models. (A-D) Enrichment is the total number of significant metabolites per pathway, correcting for pathway size. DA treatment and ageing in brain, gut, muscle and whole flies. Metabolic pathways that are altered by DA in the brain (A), gut (B), muscle (C) and the whole fly (D) are found in both PLAN models.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 32 Not checked · 85 Own results and interpretations

61 more claims

Create a free account to see all 117 claims and to verify the 49 references still open.

See all claims — free account
  • It may state two separate claims as one. 34
  • Probably not a substantial claim. 26

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Cited by

Still being checked.

Metadata

Authors
Zhang, B., Dunn, E., Williams, R. S. B., Snowden, S., & Augustin, H.
Affiliations
Royal Holloway University of London (GB)
Corresponding author
Augustin, Hrvoje
Venue
Disease Models & Mechanisms
Published
2025-11-01
Volume
18
Issue
11
ISSN
  • 1754-8403 (ISSN-L)
  • 1754-8411
OpenAlex
W4415907865
Cited by
0
References
150
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Disease Models & Mechanisms (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Royal Holloway
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
PLA2G6-associated neurodegeneration, capric acid, medium-chain fatty acids, lifespan extension, Drosophila melanogaster, neurodegeneration, mTOR, heat shock response, sirtuins, autophagy, mitochondrial function, gut metabolomics, ABC transporters, purine metabolism, cAMP signaling, neuroactive ligand-receptor interaction
MeSH terms
Loss of Function Mutation, Animals, Decanoic Acids, Disease Models, Animal, Drosophila melanogaster, Female, Longevity, Signal Transduction, Neuroaxonal Dystrophies, Drosophila Proteins, Group X Phospholipases A2, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.